Related Experiment Video
Updated: Mar 16, 2026
15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
10.1K
Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development.
Trends in Pharmacological Sciences
|August 25, 2016
Summary
A new model aims to overcome challenges in developing progressive multiple sclerosis (MS) treatments. It fosters collaboration among industry, academia, and patients to speed up research for effective therapies.
Area of Science:
- Neuroscience
- Clinical Research
- Pharmaceutical Development
Background:
- Progressive multiple sclerosis (MS) lacks effective treatments.
- Barriers hinder the development of therapies for progressive MS.
- Industry and academic collaboration is crucial for advancing MS research.
Purpose of the Study:
- To introduce a novel approach for addressing treatment development barriers in progressive MS.
- To promote collaboration between industry, academia, and patient organizations.
- To accelerate the discovery of safe and effective progressive MS treatments.
Main Methods:
- The Progressive MS Alliance Industry Forum convened stakeholders.
- A collaborative model was proposed to overcome identified barriers.
- Strategies for accelerating research were discussed.
Main Results:
- A new collaborative framework for progressive MS drug development was outlined.
- Enhanced partnerships between industry, academia, and patient groups were emphasized.
- The model aims to streamline research and expedite therapeutic advancements.
Conclusions:
- The proposed model offers a promising strategy to accelerate the development of treatments for progressive MS.
- Collaboration is key to overcoming challenges in progressive MS research.
- This initiative supports the goal of finding effective therapies for patients with progressive MS.
Related Concept Videos
01:26Drug Discovery: Overview
12.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.8K
01:26Drug Administration and Therapy Phases: Overview
1.6K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.6K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
59
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
59
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
405
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
405
01:03Drug Control Governance: Regulatory Bodies and Their Impact
638
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
638
01:25Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K